Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Immunisation, Lymph node pain, Musculoskeletal stiffness
Clinical narrative: Neck stiffness; Left Armpit soreness approximately 24-48 hours post-vaccination; Left arm pit soreness (Lymph node); Dose 3; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 45 year-old female patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 05Oct2021 12:30 (Lot number: FF8841) at the age of 45 years as dose 3 (booster), single for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: FLUCELVAX QUADRIVALENT taken for influenza immunisation, start date: 05Oct2021; PROBIOTICS; IRON; VIT D [VITAMIN D NOS]. Vaccination history included: Bnt162b2 (Dose 2, lot number=EL3247, administrator route=Intramuscular, administration time=11:00 AM, location=Right arm), administration date: 18Feb2021, when the patient was 45 years old, for COVID-19 Immunization; Bnt162b2 (Dose 1, lot number=EL3247, administrator route=Intramuscular, administration time=11:20 AM, location=Left arm), administration date: 28Jan2021, when the patient was 45 years old, for COVID-19 Immunization. The following information was reported: IMMUNISATION (non-serious) with onset 05Oct2021 12:30, outcome "unknown", described as "Dose 3"; MUSCULOSKELETAL STIFFNESS (non-serious) with onset 06Oct2021 12:30, outcome "recovered" (13Oct2021), described as "Neck stiffness"; AXILLARY PAIN (non-serious) with onset 06Oct2021 12:30, outcome "recovered" (13Oct2021), described as "Left Armpit soreness approximately 24-48 hours post-vaccination"; LYMPH NODE PAIN (non-serious) with onset 06Oct2021 12:30, outcome "recovered" (13Oct2021), described as "Left arm pit soreness (Lymph node)". Therapeutic measures were not taken as a result of musculoskeletal stiffness. Therapeutic measures were taken as a result of axillary pain, lymph node pain.  Additional information: Other vaccine in four weeks was reported as no. Other medications in two weeks: BC, VitD, Probiotics, Iron supplement. The patient had no known allergies. Prior vaccinations (within 4 weeks) was reported as Flucelvax quad (Manufacturer: Seqirus), Batch/Lot: 309613, via intramuscular in left arm on 05Oct2021. Complete only if a 3rd dose was administered, check one option: Booster dose due to high risk of frequent institutional or occupational exposure to coronavirus (and at risk of serious COVID-19 complications). No covid prior vaccination and no covid tested post vaccination. It was reported that, the patient experienced left armpit soreness approximately 24-48 hours post-vaccination. Stated that, did not immediately make connection between soreness and vaccination. 48hrs: Neck stiffness. The reporter considered the events as non-serious. The events neck stiffness 1 week, armpit soreness in 1 week, treated with aspirin only, was fully recovered. Relevant test was reported as none. Specific relevant test for thromboembolic events with thrombocytopenia was reported as none.  Follow-up attempts are completed. No further information is expected.